Effect of arm-ergometry versus treadmill supervised exercise training in patients with peripheral artery disease: the ARMEX randomized clinical trial

Centro Hospitalar Universitário de Santo António0 个研究点目标入组 56 人开始时间: 2024年3月21日最近更新: 2024年4月1日

适应症

试验速览

暂无简介。

•1. Patients with PAD older than 18 years old referred to the Cardiovascular Rehabilitation Unit
•2. PAD was diagnosed through a clinical history and physical examination and confirmed by an ankle-brachial index (ABI) =0.90 and/or an ABI decrease =10% after a symptom-limited treadmill stress test
•3. Patients able to walk at a speed of at least 3.2 Km/h
•4. Able to participate in a supervised exercise program for 12 weeks
•5. No change in medication for PAD (cilostazol, pentoxifylline, statin and antiplatelet therapy) at least 3 months prior to study enrollment. Medication remained unchanged during the study intervention period.

•1. PAD Leriche-Fontaine stages I, III or IV
•2. A revascularization procedure during the previous 12 months
•3. Other chronic conditions causing exercise impairment more than PAD
•4. Acute cardiovascular event less than 3 months prior to enrollment
•5. Clinical contraindications for physical exercise practice, according to current guidelines

发起方

Centro Hospitalar Universitário de Santo António